vs
Flora Growth Corp.（FLGC）与奥驰亚（MO）财务数据对比。点击上方公司名可切换其他公司
Flora Growth Corp.净利率更高（16804.7% vs 19.1%，领先16785.6%）。Flora Growth Corp.同比增速更快（87.1% vs -2.1%）。奥驰亚自由现金流更多（$3.2B vs $-3.2M）。过去两年奥驰亚的营收复合增速更高（2.4% vs -21.2%）
Flora Growth Corp是一家全球化大麻与健康产品企业，主营优质大麻及大麻衍生物的种植、加工与分销，产品涵盖大麻基快消品、护肤系列及药用制剂，主要服务拉美、北美及欧洲的娱乐与医用大麻消费市场。
奥驰亚集团是美国头部烟草企业，通过旗下子公司生产销售可燃烟草与口服类烟草相关产品，核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草，以及on!口服尼古丁袋，产品主要供应批发商、分销商及大型零售客户。
FLGC vs MO — 直观对比
营收规模更大
MO
是对方的-8938.8倍
$-654.0K
营收增速更快
FLGC
高出89.3%
-2.1%
净利率更高
FLGC
高出16785.6%
19.1%
自由现金流更多
MO
多$3.2B
$-3.2M
两年增速更快
MO
近两年复合增速
-21.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $-654.0K | $5.8B |
| 净利润 | $-109.9M | $1.1B |
| 毛利率 | 673.4% | 62.1% |
| 营业利润率 | 22606.0% | 28.2% |
| 净利率 | 16804.7% | 19.1% |
| 营收同比 | 87.1% | -2.1% |
| 净利润同比 | -1692.9% | -63.2% |
| 每股收益（稀释后） | $-34.29 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLGCMO
| Q4 25 | $-654.0K | $5.8B | ||
| Q3 25 | $9.7M | $6.1B | ||
| Q2 25 | $14.8M | $6.1B | ||
| Q1 25 | $11.8M | $5.3B | ||
| Q4 24 | $-5.1M | $6.0B | ||
| Q3 24 | $7.2M | $6.3B | ||
| Q2 24 | $15.7M | $6.2B | ||
| Q1 24 | — | $5.6B |
净利润FLGCMO
| Q4 25 | $-109.9M | $1.1B | ||
| Q3 25 | $-6.7M | $2.4B | ||
| Q2 25 | $-2.4M | $2.4B | ||
| Q1 25 | $-758.0K | $1.1B | ||
| Q4 24 | $-6.1M | $3.0B | ||
| Q3 24 | $-3.8M | $2.3B | ||
| Q2 24 | $-2.6M | $3.8B | ||
| Q1 24 | — | $2.1B |
毛利率FLGCMO
| Q4 25 | 673.4% | 62.1% | ||
| Q3 25 | 3.4% | 62.8% | ||
| Q2 25 | 19.1% | 63.1% | ||
| Q1 25 | 24.5% | 61.8% | ||
| Q4 24 | 104.6% | 60.3% | ||
| Q3 24 | 6.8% | 60.8% | ||
| Q2 24 | 20.2% | 59.2% | ||
| Q1 24 | — | 58.8% |
营业利润率FLGCMO
| Q4 25 | 22606.0% | 28.2% | ||
| Q3 25 | -33.5% | 53.2% | ||
| Q2 25 | -17.3% | 52.9% | ||
| Q1 25 | -8.3% | 34.0% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | -29.2% | 50.4% | ||
| Q2 24 | -22.6% | 40.8% | ||
| Q1 24 | — | 48.0% |
净利率FLGCMO
| Q4 25 | 16804.7% | 19.1% | ||
| Q3 25 | -68.3% | 39.1% | ||
| Q2 25 | -16.3% | 39.0% | ||
| Q1 25 | -6.4% | 20.5% | ||
| Q4 24 | 120.5% | 50.9% | ||
| Q3 24 | -52.1% | 36.6% | ||
| Q2 24 | -16.8% | 61.2% | ||
| Q1 24 | — | 38.2% |
每股收益（稀释后）FLGCMO
| Q4 25 | $-34.29 | $0.67 | ||
| Q3 25 | $-9.05 | $1.41 | ||
| Q2 25 | $-0.11 | $1.41 | ||
| Q1 25 | $-0.04 | $0.63 | ||
| Q4 24 | $-38.40 | $1.78 | ||
| Q3 24 | $-11.03 | $1.34 | ||
| Q2 24 | $-0.21 | $2.21 | ||
| Q1 24 | — | $1.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $4.5B |
| 总债务越低越好 | $53.5M | $25.7B |
| 股东权益账面价值 | $70.6M | $-3.5B |
| 总资产 | $130.2M | $35.0B |
| 负债/权益比越低杠杆越低 | 0.76× | — |
8季度趋势，按日历期对齐
现金及短期投资FLGCMO
| Q4 25 | $5.6M | $4.5B | ||
| Q3 25 | $13.1M | $3.5B | ||
| Q2 25 | $1.5M | $1.3B | ||
| Q1 25 | $3.7M | $4.7B | ||
| Q4 24 | $5.2M | $3.1B | ||
| Q3 24 | $4.2M | $1.9B | ||
| Q2 24 | $6.1M | $1.8B | ||
| Q1 24 | — | $3.6B |
总债务FLGCMO
| Q4 25 | $53.5M | $25.7B | ||
| Q3 25 | — | $25.7B | ||
| Q2 25 | — | $24.7B | ||
| Q1 25 | — | $26.1B | ||
| Q4 24 | $2.1M | $24.9B | ||
| Q3 24 | — | $25.2B | ||
| Q2 24 | — | $25.0B | ||
| Q1 24 | — | $25.0B |
股东权益FLGCMO
| Q4 25 | $70.6M | $-3.5B | ||
| Q3 25 | $64.9M | $-2.6B | ||
| Q2 25 | $4.0M | $-3.3B | ||
| Q1 25 | $4.8M | $-3.5B | ||
| Q4 24 | $4.5M | $-2.2B | ||
| Q3 24 | $4.3M | $-3.5B | ||
| Q2 24 | $7.3M | $-3.0B | ||
| Q1 24 | — | $-5.1B |
总资产FLGCMO
| Q4 25 | $130.2M | $35.0B | ||
| Q3 25 | $74.0M | $35.0B | ||
| Q2 25 | $22.7M | $32.3B | ||
| Q1 25 | $22.4M | $35.8B | ||
| Q4 24 | $26.2M | $35.2B | ||
| Q3 24 | $29.3M | $34.2B | ||
| Q2 24 | $30.1M | $34.4B | ||
| Q1 24 | — | $36.5B |
负债/权益比FLGCMO
| Q4 25 | 0.76× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | $3.3B |
| 自由现金流经营现金流 - 资本支出 | $-3.2M | $3.2B |
| 自由现金流率自由现金流/营收 | 487.6% | 54.4% |
| 资本支出强度资本支出/营收 | -4.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 2.93× |
| 过去12个月自由现金流最近4个季度 | $-6.0M | $9.1B |
8季度趋势，按日历期对齐
经营现金流FLGCMO
| Q4 25 | $-3.2M | $3.3B | ||
| Q3 25 | $100.0K | $3.1B | ||
| Q2 25 | $-2.9M | $205.0M | ||
| Q1 25 | $-2.7M | $2.7B | ||
| Q4 24 | $-1.3M | $3.3B | ||
| Q3 24 | $-2.1M | $2.6B | ||
| Q2 24 | $-265.0K | $-75.0M | ||
| Q1 24 | — | $2.9B |
自由现金流FLGCMO
| Q4 25 | $-3.2M | $3.2B | ||
| Q3 25 | $91.0K | $3.0B | ||
| Q2 25 | $-3.0M | $173.0M | ||
| Q1 25 | $-2.8M | $2.7B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | $-2.1M | $2.6B | ||
| Q2 24 | $-291.0K | $-104.0M | ||
| Q1 24 | — | $2.8B |
自由现金流率FLGCMO
| Q4 25 | 487.6% | 54.4% | ||
| Q3 25 | 0.9% | 50.1% | ||
| Q2 25 | -20.0% | 2.8% | ||
| Q1 25 | -23.3% | 51.0% | ||
| Q4 24 | — | 55.1% | ||
| Q3 24 | -29.0% | 41.2% | ||
| Q2 24 | -1.9% | -1.7% | ||
| Q1 24 | — | 51.0% |
资本支出强度FLGCMO
| Q4 25 | -4.4% | 1.6% | ||
| Q3 25 | 0.1% | 0.9% | ||
| Q2 25 | 0.4% | 0.5% | ||
| Q1 25 | 0.2% | 0.7% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.2% | 0.5% | ||
| Q1 24 | — | 0.6% |
现金转化率FLGCMO
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 0.09× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | -0.02× | ||
| Q1 24 | — | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLGC
暂无分部数据
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |
